PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gregorc V et al. - NGR–hTNF plus doxorubicin was administered safely and showed promising activity in patients pre-treated with anthracyclines. The dose level of 0.8 ug m-2 NGR–hTNF plus doxorubicin 75 mg m-2 was selected for phase II development.

Today in Clinical Pharmacology...keeping you current

No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/17/09

Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/17/09

Optimizing Epidural Fentanyl Loading Dose for Early Labor Pain
Acta Anaesthesiologica Taiwanica, 12/17/09

Today in Hematology/Oncology...keeping you current

The predictive value of genes of the TGF-beta1 pathway in multimodally treated squamous cell carcinoma of the esophagus
International Journal of Colorectal Disease, 12/17/09

Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients
Journal of Gastrointestinal Surgery, 12/17/09

Gastric carcinoma with simultaneous Virchow's lymph node and liver metastases: a case report.
The Internet Journal of Gastroenterology, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address